HFRG
IMUX icon

Houlihan Financial Resource Group’s Immunic IMUX Stock Holding History

Houlihan Financial Resource Group’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$4K Buy
+23
New +$3.77K ﹤0.01% 303

Other funds holding IMUX

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Houlihan Financial Resource Group's IMUX Position: Q3 2020 in Review

Houlihan Financial Resource Group opened a new position in Immunic (IMUX) in Q3 2020: 23 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #303 among its holdings.

66 funds tracked by Wall St. Rank hold IMUX as of Q3 2020.

  • Houlihan Financial Resource Group held 23 shares of Immunic worth $4K as of Q3 2020.
  • Immunic was a new Houlihan Financial Resource Group position in Q3 2020.
  • Immunic made up ﹤0.01% of Houlihan Financial Resource Group's portfolio in Q3 2020, its #303 holding.
  • 66 funds tracked by Wall St. Rank held Immunic as of Q3 2020.

Based on Houlihan Financial Resource Group's 13F filing for Q3 2020, filed 13 Nov 2020.